QQQ   315.30 (-0.97%)
AAPL   124.01 (-0.89%)
MSFT   230.95 (-1.25%)
FB   257.22 (-0.69%)
GOOGL   2,044.73 (-0.96%)
TSLA   688.62 (+0.32%)
AMZN   3,054.78 (-1.28%)
NVDA   525.16 (-2.07%)
BABA   236.13 (+0.73%)
CGC   34.56 (-1.96%)
GE   13.33 (+2.70%)
MU   92.67 (+1.73%)
NIO   44.06 (+1.78%)
AMD   83.18 (-1.13%)
T   28.34 (+0.43%)
F   12.26 (-2.31%)
ACB   10.83 (-1.81%)
DIS   195.01 (+0.55%)
BA   229.86 (+3.01%)
NFLX   530.42 (-3.18%)
PFE   33.59 (+0.24%)
QQQ   315.30 (-0.97%)
AAPL   124.01 (-0.89%)
MSFT   230.95 (-1.25%)
FB   257.22 (-0.69%)
GOOGL   2,044.73 (-0.96%)
TSLA   688.62 (+0.32%)
AMZN   3,054.78 (-1.28%)
NVDA   525.16 (-2.07%)
BABA   236.13 (+0.73%)
CGC   34.56 (-1.96%)
GE   13.33 (+2.70%)
MU   92.67 (+1.73%)
NIO   44.06 (+1.78%)
AMD   83.18 (-1.13%)
T   28.34 (+0.43%)
F   12.26 (-2.31%)
ACB   10.83 (-1.81%)
DIS   195.01 (+0.55%)
BA   229.86 (+3.01%)
NFLX   530.42 (-3.18%)
PFE   33.59 (+0.24%)
QQQ   315.30 (-0.97%)
AAPL   124.01 (-0.89%)
MSFT   230.95 (-1.25%)
FB   257.22 (-0.69%)
GOOGL   2,044.73 (-0.96%)
TSLA   688.62 (+0.32%)
AMZN   3,054.78 (-1.28%)
NVDA   525.16 (-2.07%)
BABA   236.13 (+0.73%)
CGC   34.56 (-1.96%)
GE   13.33 (+2.70%)
MU   92.67 (+1.73%)
NIO   44.06 (+1.78%)
AMD   83.18 (-1.13%)
T   28.34 (+0.43%)
F   12.26 (-2.31%)
ACB   10.83 (-1.81%)
DIS   195.01 (+0.55%)
BA   229.86 (+3.01%)
NFLX   530.42 (-3.18%)
PFE   33.59 (+0.24%)
QQQ   315.30 (-0.97%)
AAPL   124.01 (-0.89%)
MSFT   230.95 (-1.25%)
FB   257.22 (-0.69%)
GOOGL   2,044.73 (-0.96%)
TSLA   688.62 (+0.32%)
AMZN   3,054.78 (-1.28%)
NVDA   525.16 (-2.07%)
BABA   236.13 (+0.73%)
CGC   34.56 (-1.96%)
GE   13.33 (+2.70%)
MU   92.67 (+1.73%)
NIO   44.06 (+1.78%)
AMD   83.18 (-1.13%)
T   28.34 (+0.43%)
F   12.26 (-2.31%)
ACB   10.83 (-1.81%)
DIS   195.01 (+0.55%)
BA   229.86 (+3.01%)
NFLX   530.42 (-3.18%)
PFE   33.59 (+0.24%)
Log in
ASX:CYP

Cynata Therapeutics News Headlines

Add
Compare
Today's Range N/A
50-Day Range
A$0.68
MA: A$0.68
A$0.68
52-Week Range N/A
Volume159,853 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cynata Therapeutics (ASX CYP) News Headlines Today

Source:
SourceHeadline
Expert view: Here’s what investors are getting wrong about Australian health stocksExpert view: Here’s what investors are getting wrong about Australian health stocks
msn.com - February 22 at 6:24 PM
Global Mesenchymal Stem Cells Advances and Applications Market Report 2021 - ResearchAndMarkets.comGlobal Mesenchymal Stem Cells Advances and Applications Market Report 2021 - ResearchAndMarkets.com
benzinga.com - February 14 at 12:37 AM
MoneyTalks: This biotech focused fund explains why it invested $15m in these 2 ASX stocksMoneyTalks: This biotech focused fund explains why it invested $15m in these 2 ASX stocks
msn.com - February 10 at 6:00 PM
Allogeneic Stem Cells Market Size with Focus on Emerging Technologies, Competitive Landscape, Regional Analysis and Forecasts to 2025Allogeneic Stem Cells Market Size with Focus on Emerging Technologies, Competitive Landscape, Regional Analysis and Forecasts to 2025
marketwatch.com - February 3 at 1:16 PM
Stem Cells Market Growth Scenario, Industry Size, Share Analysis, Trends, Competitive Analysis and Global Forecasts to 2027Stem Cells Market Growth Scenario, Industry Size, Share Analysis, Trends, Competitive Analysis and Global Forecasts to 2027
marketwatch.com - February 2 at 7:35 PM
Are these 4 ASX medical shares set for a healthy 2021?Are these 4 ASX medical shares set for a healthy 2021?
fool.com.au - January 6 at 11:21 PM
Cynata Therapeutics Limited (CYYNF)Cynata Therapeutics Limited (CYYNF)
nasdaq.com - October 18 at 5:45 PM
Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease StudyCymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
finance.yahoo.com - September 8 at 11:14 AM
Patient Enrolment Opens in COVID-19 Clinical TrialPatient Enrolment Opens in COVID-19 Clinical Trial
finance.yahoo.com - August 24 at 8:35 AM
StockTalk: Biotechs set to boom with clinical trial floodgates openStockTalk: Biotechs set to boom with clinical trial floodgates open
www.msn.com - June 5 at 8:19 AM
2020 Insights on the Worldwide Induced Pluripotent Stem Cell Industry - ResearchAndMarkets.com2020 Insights on the Worldwide Induced Pluripotent Stem Cell Industry - ResearchAndMarkets.com
www.benzinga.com - May 12 at 6:25 PM
10 at 10: These ASX stocks are shooting through the skies this morning10 at 10: These ASX stocks are shooting through the skies this morning
www.msn.com - May 7 at 11:01 PM
FUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy ApplicationsFUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy Applications
www.bloomberg.com - April 25 at 12:51 AM
Are we mortgaging the future as COVID-19 closes clinical trials?Are we mortgaging the future as COVID-19 closes clinical trials?
www.msn.com - April 21 at 2:51 PM
Preclinical Study Showing Beneficial Effects of Cymerus™ MSCs in Acute Respiratory Distress Syndrome Accepted for Publication in Leading Peer-Reviewed JournalPreclinical Study Showing Beneficial Effects of Cymerus™ MSCs in Acute Respiratory Distress Syndrome Accepted for Publication in Leading Peer-Reviewed Journal
finance.yahoo.com - April 17 at 12:02 PM
Market Update and Additional A$618k R&D Tax RefundMarket Update and Additional A$618k R&D Tax Refund
finance.yahoo.com - March 11 at 8:46 AM
UK Regulatory Authority Approves Cynatas Phase 2 Clinical Trial in Critical Limb IschaemiaUK Regulatory Authority Approves Cynata's Phase 2 Clinical Trial in Critical Limb Ischaemia
www.benzinga.com - January 14 at 4:11 PM
UK Regulatory Authority Approves Cynata’s Phase 2 Clinical Trial in Critical Limb IschaemiaUK Regulatory Authority Approves Cynata’s Phase 2 Clinical Trial in Critical Limb Ischaemia
finance.yahoo.com - January 14 at 4:11 PM
Why this small cap biotech ASX share zoomed higher on TuesdayWhy this small cap biotech ASX share zoomed higher on Tuesday
www.fool.com.au - January 7 at 7:36 AM
Cymerus™ MSCs Effective in Preclinical Model of SepsisCymerus™ MSCs Effective in Preclinical Model of Sepsis
finance.yahoo.com - December 5 at 1:09 PM
Cynata Files Application to Commence Phase 2 Clinical Trial in Critical Limb IschaemiaCynata Files Application to Commence Phase 2 Clinical Trial in Critical Limb Ischaemia
finance.yahoo.com - November 25 at 8:28 AM
Cynata Advances Toward Phase 2 Clinical Trial of Cymerus(TM) MSCs in Patients with OsteoarthritisCynata Advances Toward Phase 2 Clinical Trial of Cymerus(TM) MSCs in Patients with Osteoarthritis
finance.yahoo.com - October 4 at 5:02 PM
Fujifilm licenses Cynata stem cell optionFujifilm licenses Cynata stem cell option
au.finance.yahoo.com - September 18 at 12:41 AM
Fujifilm Exercises License Option in GvHDFujifilm Exercises License Option in GvHD
finance.yahoo.com - September 17 at 7:40 PM
Cynata confirms receipt of indicative, non-binding proposalCynata confirms receipt of indicative, non-binding proposal
finance.yahoo.com - August 7 at 3:38 PM
ASX small caps outperform on the Aussie dollar strength and rate cut betsASX small caps outperform on the Aussie dollar strength and rate cut bets
au.finance.yahoo.com - July 20 at 10:14 AM
Why Cynata, Medical Developments International, NAB, & Resolute charged higherWhy Cynata, Medical Developments International, NAB, & Resolute charged higher
au.finance.yahoo.com - July 19 at 10:52 AM
Cynata Therapeutics share price rockets higher on takeover newsCynata Therapeutics share price rockets higher on takeover news
au.finance.yahoo.com - July 19 at 10:52 AM
The Stem Cell Triple Play: 3 Companies With Great Value DriversThe Stem Cell Triple Play: 3 Companies With Great Value Drivers
seekingalpha.com - June 14 at 8:40 PM
A host of ASX small caps just got a boost from positive news out of the labA host of ASX small caps just got a boost from positive news out of the lab
www.msn.com - May 7 at 8:10 AM
Dr Boreham’s Crucible: Is Cynata Therapeutics’ Fujifilm partnership all puff and no blow?Dr Boreham’s Crucible: Is Cynata Therapeutics’ Fujifilm partnership all puff and no blow?
www.msn.com - May 6 at 7:48 AM
Announcing: Cynata Therapeutics (ASX:CYP) Stock Increased An Energizing 267% In The Last Five YearsAnnouncing: Cynata Therapeutics (ASX:CYP) Stock Increased An Energizing 267% In The Last Five Years
finance.yahoo.com - April 22 at 7:31 AM
Cynata Receives Favourable Advice from UK MHRA on CLI Clinical TrialCynata Receives Favourable Advice from UK MHRA on CLI Clinical Trial
finance.yahoo.com - March 12 at 3:20 PM
What Kind Of Shareholder Appears On The Cynata Therapeutics Limited’s (ASX:CYP) Shareholder Register?What Kind Of Shareholder Appears On The Cynata Therapeutics Limited’s (ASX:CYP) Shareholder Register?
finance.yahoo.com - March 6 at 5:58 AM
Want To Invest In Cynata Therapeutics Limited (ASX:CYP)? Here’s How It Performed LatelyWant To Invest In Cynata Therapeutics Limited (ASX:CYP)? Here’s How It Performed Lately
finance.yahoo.com - February 11 at 4:55 PM
When Can We Expect A Profit From Cynata Therapeutics Limited (ASX:CYP)?When Can We Expect A Profit From Cynata Therapeutics Limited (ASX:CYP)?
finance.yahoo.com - February 11 at 4:55 PM
These Fundamentals Make Cynata Therapeutics Limited (ASX:CYP) Truly Worth Looking AtThese Fundamentals Make Cynata Therapeutics Limited (ASX:CYP) Truly Worth Looking At
finance.yahoo.com - February 11 at 4:55 PM
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with OsteoarthritisNHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
finance.yahoo.com - February 11 at 4:55 PM
Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHDCynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD
finance.yahoo.com - February 11 at 4:55 PM
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.